KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Twist Bioscience (TWST) Other Operating Expenses (2017 - 2025)

Twist Bioscience (TWST) has disclosed Other Operating Expenses for 9 consecutive years, with $49.7 million as the latest value for Q4 2025.

  • Quarterly Other Operating Expenses rose 8.4% to $49.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $96.5 million through Dec 2025, up 110.34% year-over-year, with the annual reading at $5.9 million for FY2023, 58.49% down from the prior year.
  • Other Operating Expenses for Q4 2025 was $49.7 million at Twist Bioscience, up from -$48.8 million in the prior quarter.
  • The five-year high for Other Operating Expenses was $49.7 million in Q4 2025, with the low at -$48.8 million in Q3 2025.
  • Average Other Operating Expenses over 5 years is $11.6 million, with a median of $3.5 million recorded in 2021.
  • The sharpest move saw Other Operating Expenses crashed 97.92% in 2021, then surged 324.22% in 2022.
  • Over 5 years, Other Operating Expenses stood at $2.8 million in 2021, then surged by 46.32% to $4.1 million in 2022, then tumbled by 85.95% to $581000.0 in 2023, then soared by 7795.52% to $45.9 million in 2024, then increased by 8.4% to $49.7 million in 2025.
  • According to Business Quant data, Other Operating Expenses over the past three periods came in at $49.7 million, -$48.8 million, and $48.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.